Juntendo Medical Journal, 2026 Original Articles Juntendo Medical Journal 2026 Association between Clinical Risk Scores and Patient-reported Symptom Severity in ICU Patients with Septic Shock Hafiza Maryam MAQBOOL1), Tabassum PARVEEN2), Onayemi OLUWASEUN E.3), Anas Salaheldin Ahmed KHALIL4), Sohail Anjum AWAN5), Tuba Ali FARHAN6), Saad Ali KHAN7), Muaz Shafique Ur REHMAN8), Ahila Abdulameer Majeed ABU-NAYLA9), Sajeda Omar SALEM10), Esra Mhd. Nour BARODI11), Joman Tha’er Izzat AWWAD12), Mohammed SHIHAS13), Majd Aldin OUDEH14) 1)Department of Acute Medicine, Kingston and Richmond NHS Foundation Trust, London, United Kingdom 2)Department of Medicine, Khaja Banda Nawaz Institute of Medical Sciences, Gulbarga, India 3)Department of Emergency Medicine, Royal Surrey County Hospital (RSCH), Guildford, United Kingdom 2025. The data were collected through a structured questionnaire that encompassed demographic char­ acteristics, clinical parameters, validated risk scores, and patient-reported symptom severity. Researchers who received the proper training contacted patients who met the trial criteria or their legally authorised representatives to inform Juntendo Medical Journal, 2026 them about the study's aims and methods and to obtain written consent before the onset of data collection. The study participants' anonymity was guaranteed, and they were informed of their with­ drawal right, which could be exercised at any time without adverse consequences for their medical treatment. The aforementioned data management practice led to the use of standard methods for collecting information, a reduction in participants' irritation, and an increase in data reliability. Recruitment and sample As no data were available on the prevalence of symptom burden in ICU patients with septic shock at their local hospitals, a conservative value of 0.5 was used to calculate the sample size. This p-value was plugged into the sample size calculation formula, along with 95% confidence interval (Z = 1.96) and a 0.05 margin of error, to yield the required sample size10). The sampling method in the study was influenced by logistical limitations, so patients with septic shock in the ICU were recruited through convenience sampling. Conse­ quently, the sample might not be accurately repre­ sentative of the normal demographic representa­ tion of the patients with septic shock in the ICU, who, in many cases, are old and have many comorbid conditions. All of the patients in the intensive care unit who were recently diagnosed with septic shock were invited to participate in the study. Of the patients screened, 433 met the eligibility criteria, signed the informed consent form, and were analysed as part of the study. The use of convenience sampling enabled the recruitment of participants in the crit­ ical care environment quickly. Convenience sampling may have resulted in a younger, healthier ICU cohort compared with the typical septic shock population, limiting generalizability. Eligibility criteria The research was conducted on adults who were 18 years old and older and were diagnosed with septic shock and admitted to the ICU. The inclu­ sion criteria required complete clinical data for these patients and that they be able to participate either directly or through a surrogate respondent when clinically suitable for symptom assessment. If a patient had incomplete medical records, was admitted for non-septic shock, or could not give consent and had no legally authorised representa­ tive, that patient was excluded. Furthermore, patients with advance directives, instructions that limit active management, were discharged before the researchers finished data collection and were therefore excluded. Instruments and procedures Data collection was performed using a structured questionnaire comprising three main parts: demo­ graphic and clinical characteristics, clinical risk scores, and patient-reported symptom severity. Demo­ graphic data comprised age, sex and relevant clin­ ical information retrieved from medical charts. The quick Sequential Organ Failure Assessment (qSOFA) score was proposed by Seymour et al. in 2016 in conjunction with the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). It is a bedside screening tool that has been simplified and developed for quickly identi­ fying patients with suspected infection who are at risk of adverse outcomes outside the ICU. The qSOFA score is based on three clinical criteria: systolic blood pressure ≤ 100 mmHg, respiratory rate ≥ 22 breaths per minute, and altered mental status (Glasgow Coma Scale score <15). Each of the three criteria is assigned 1 point, and a total score between 0 and 3 is possible. A qSOFA score of two or more is deemed a sign of heightened risk of adverse outcomes, such as organ failure and death. Because of its straightforwardness and reli­ ance on readily accessible clinical measures, qSOFA is widely used in emergent and intensive medical care to quickly classify risk among septic patients11). The qSOFA score was used in the original English version in this study, without modification. Even though qSOFA was initially developed for early risk stratification in the absence of the ICU, included in this exploratory study to examine its association with patient-reported symptom burden in ICU patients, recognizing that it is not validated for ICU populations. The National Early Warning Score 2 (NEWS 2) was created by the Royal College of Physicians (RCP) in the United Kingdom, and the revised edition was released in 2017. The NEWS 2 was designed to detect the clinical deterioration of acutely ill patients in hospitals at an early stage and includes patients suffering from sepsis and septic 3 Maqbool HM, et al: Clinical risk scores & symptoms in septic shock shock. The scoring consists of six daily-measured physiological factors: respiratory rate, oxygen satu­ ration, systolic blood pressure, heart rate, tempera­ ture, and consciousness level measured by the AVPU scale, plus a plus for the use of extra oxygen. Each parameter is evaluated on a scale of 0 to 3 based on the allowed limits, and the total score is calculated from 0 to 20. A NEWS 2 score of ≥ 5 indicates that an immediate clinical evaluation is required, and a score of ≥ 7 indicates a very highrisk patient who should receive care first12). The NEWS 2 system was used in this study in its offi­ cial English version. The researchers utilised the patient-reported symptom severity scale in the study to system­ atically evaluate subjective symptoms commonly observed in patients with septic shock in the ICU. Participants were asked to rate the intensity of seven symptoms: fatigue or weakness, dizziness or lightheadedness, shortness of breath, pounding or rapid heartbeat, faintness or low blood pressure, confusion or poor concentration, and nausea or vomiting, all occurring within the last 24 hours. These seven items were selected based on a review of previous ICU symptom studies and clinician consensus on the most common and clinically rele­ vant symptoms experienced by patients with septic shock. All symptoms were rated using a five-point scale with 0 (none) to 4 (very severe), and a Total Symptom Severity Score was obtained (0 to 28), where higher scores indicated higher symptom burden. The overall scores were also divided into four groups: 0-7 (mild), 8-14 (moderate), 15-21 (severe), and 22-28 (very severe). This scale enabled a systematic examination of patient-re­ ported symptoms and their association with clinical risk scores. This is a locally developed patientreported symptom severity scale. It has not been subject to formal validation, such as reliability (e.g. Cronbach's alpha) and construct validity tests, nor has it been applicable to external populations. Consequently, the findings from this scale must be treated as exploratory associations rather than conclusive indicators of symptom severity. Patients completed the questionnaires themselves or with assistance from trained research staff, depending on their condition. The completed ques­ tionnaires were verified and stored in a safe place for later analysis. 4 Statistical plan The data analysis was performed using IBM SPSS Statistics version 26. For categorical vari­ ables, descriptive statistics such as frequencies and percentages were utilised, while continuous vari­ ables were presented as means ± standard devia­ tions. Associations between qSOFA, NEWS 2, and PRSS scores were evaluated by Pearson correla­ tion analysis. Gender differences were compared using independent-samples t-tests, and one-way ANOVA was used to investigate differences among age groups, reporting partial eta-squared (η2) as a measure of effect size. Multiple linear regression was used to identify factors associated with PRSS, with the independent variables being qSOFA, NEWS 2, age, gender, chronic disease, and smoking status. A two-tailed approach was used for all tests, and p-values < 0.05 were considered statistically significant. By utilising this method, it was possible to evaluate the relationships between clinical risk scores and patient-reported symptom severity, to test for significant differences between groups, and to identify the main predictors of symptom burden in ICU patients with septic shock. Multicollinearity among independent variables was assessed using the Variance Inflation Factor (VIF), and all values were below the commonly accepted threshold, indi­ cating no significant multicollinearity. Ethical standards The study was conducted in accordance with the basic ethical principles for human research. The institutional review board of Lewisham and Green­ wich NHS Trust hospital (IRB/LGNT/2026/EA0147) granted ethical clearance prior to the study. Participation was entirely voluntary, and written informed consent was obtained from all partici­ pants or their legally authorised representatives. All gathered data were made anonymous to guarantee privacy and kept in a secure place with limited access. The participants were told that their refusal to take part or leave would not affect their current treatment. The missing or incomplete data were handled so that the validity of the conclu­ sions remained intact. Juntendo Medical Journal, 2026 Pearson correlations among qSOFA, NEWS 2, and patient-reported symptom severity (PRSS) Significant positive correlations between patientreported symptom severity (PRSS) and all clinical severity scores are observed among 433 participants (Table 2). In particular, qSOFA scores showed moderate correlations with NEWS (r = 0.382, p < 0.001) and PRSS (r = 0.417, p < 0.001), while NEWS scores also correlated with PRSS (r = 0.356, p < 0.001). These findings demonstrate positive associ­ ations between clinical severity scores and patientreported symptom severity. Results Demographic characteristics of ICU patients with septic shock The gender imbalance among 433 participants is shown in Table 1, where the male-to-female ratio was very close, with a slight majority of females (50.8%). The most prominent age category was 18-39 years (56.6%), married (59.1%), and with a minimum education level of high school graduation (66.5%). The unemployed or homemakers accounted for almost half (48.7%). The most prevalent chronic conditions were hypertension (40.2%) and chronic kidney disease (27.3%), while 48.0% of the partici­ pants had previously smoked. In summary, the sample mainly consisted of young to middle-aged adults with moderate to high education levels and a significant burden of chronic diseases. Table 1 Gender differences in clinical severity scores (qSOFA, NEWS 2) and patient-reported symptom severity (PRSS) The gender differences were highly significant in clinical severity and symptom scores, as shown Demographic characteristics of participants (N = 433) Variable f % 18-29 years 117 27.0 30-39 years 128 29.6 Variable Age f % Student 59 13.6 Office/Professional 71 16.4 Occupation 40-49 years 91 21.0 Manual labor/Worker 60 13.9 50-59 years 53 12.2 Unemployed/Homemaker 211 48.7 60 years or above 44 10.2 Retired 32 7.4 Male 213 49.2 Diabetes 74 17.1 Female 220 50.8 Hypertension 174 40.2 Chronic kidney disease 118 27.3 Gender Known chronic disease Marital status Single 112 25.9 Heart disease/CAD 60 13.9 Married 256 59.1 None 7 1.6 Widowed/Divorced 65 15.0 Smoking status Never smoked 121 27.9 No formal education 38 8.8 Former smoker 208 48.0 Primary/Middle school 83 19.2 Current smoker 104 24.0 Educational level High school/Secondary 121 27.9 Graduate/Bachelor's 167 38.6 Postgraduate 24 5.5 Note. N = number of participants; f = frequency, % = percentage; N = 433 Table 2 Pearson correlations between qSOFA, NEWS, and PRSS (N = 433) Variables 1 2 3 Quick sequential organ failure assessment (qSOFA) - r = 0.382, t = 8.58, p < 0.001*** r = 0.417, t = 9.52, p < 0.001*** National early warning score (NEWS) - - r = 0.356, t = 7.91, p < 0.001*** Patient-reported symptom severity (PRSS) - - - Note. ***= p < 0.001 considered significant; Positive correlations indicate direct relationships; N = 433. 5 Maqbool HM, et al: Clinical risk scores & symptoms in septic shock Multiple regression analysis: factors associated with patient-reported symptom severity (PRSS) The findings of the multiple regression analysis, as presented in Table 5, revealed patient-reported symptom severity (PRSS) associated factors. PRSS scores were positively associated with qSOFA (β = 0.140, p = 0.001) and NEWS scores (β = 0.180, p = 0.001). Female gender was significantly associ­ ated with higher PRSS scores (β = 0.320, p = 0.001), whereas older age (β= -0.095, p = 0.018) and smoking (β = -0.090, p = 0.024) were associated with lower symptom levels. Presence of chronic disease was significantly associated with higher PRSS scores (β = 0.110, p = 0.002). in Table 3. Males had higher mean qSOFA (5.42 vs. 5.08, p < 0.001, d = 0.50) and NEWS scores (18.62 vs. 17.98, p < 0.001, d = 0.34) compared to females. In contrast, using the patient-reported symptom severity scale (PRSS: 13.48 vs. 12.10, p < 0.001, d = 0.67) as the measure, women reported more severe symptoms than men did. These results show statis­ tically significant gender differences in both clinical severity scores and patient-reported symptom severity. Age group comparisons of qSOFA, NEWS 2, and patient-reported symptom severity (PRSS) According to Table 4, age groups showed statis­ tically significant differences in clinical severity and patient-reported symptom scores. Older participants had higher qSOFA and NEWS scores (qSOFA: F = 13.62, p < 0.001, η2 = 0.113; NEWS: F = 3.51, p = 0.008, η² = 0.032). In contrast, higher PRSS scores were observed among younger participants, followed by a gradual decline across increasing age groups (F = 5.24, p < 0.001, η2 = 0.047). Table 3 Regression coefficients for predictors of patientreported symptom severity (PRSS) According to Figure 1, PRSS was significantly associated with qSOFA (B = 0.42, p < 0.001) and NEWS scores (B = 0.21, p < 0.01). Female gender and presence of chronic disease were positively associated with PRSS, whereas older age (B = -0.10, p = 0.05) and smoking (B = -0.25, p = 0.05) were Gender differences in qSOFA, NEWS, and PRSS scores (N = 433) Male Female (N = 213; 49.2 %); (N = 220; 50.8%); (M ± SD) (M ± SD) Variables t p 95% CI LL 95% CI UL Cohen's d Quick sequential organ failure assessment (qSOFA) 5.42 ± 0.68 5.08 ± 0.70 5.17 < 0.001*** 0.21 0.47 0.50 National early warning score (NEWS) 18.62 ± 1.92 17.98 ± 1.85 3.49 < 0.001*** 0.29 0.99 0.34 Patient-reported symptom severity (PRSS) 12.10 ± 1.88 13.48 ± 2.35 -6.94 < 0.001*** -1.78 -0.99 0.67 Note. Values are mean ± SD. t = independent-samples t-test; CI = confidence interval; d = Cohen’s effect size. Significance: *p < 0.05, **p < 0.01, ***p < 0.001. N = 433. Table 4 Age Group Differences in qSOFA, NEWS, and PRSS Scores (One-Way ANOVA, N=433) 18-29 years 30-39 years 40-49 years 50-59 years (N = 117; (N = 128; (N = 91; (N = 53; 27.0%); 29.6%); 21.0%); 12.2%); (M ± SD) (M ± SD) (M ± SD) (M ± SD) 60 years or above (N = 44; 10.2%); (M ± SD) F(4,428) p η2 Quick sequential organ failure assessment (qSOFA) 4.78 ± 0.72 5.72 ± 0.66 13.62 < 0.001*** 0.113 National early warning score (NEWS) 17.82 ± 1.76 18.14 ± 1.83 18.61 ± 1.89 19.02 ± 2.01 19.48 ± 1.92 3.51 0.008** 0.032 Patient-reported symptom severity (PRSS) 13.42 ± 2.45 14.01 ± 2.31 13.78 ± 2.02 12.86 ± 1.58 11.94 ± 1.21 5.24 < 0.001*** 0.047 Variable 5.02 ± 0.65 5.21 ± 0.70 5.38 ± 0.68 Note. All comparisons were significant at p < 0.01, < 0.001; η2 represents the partial eta-squared effect size. 6 Juntendo Medical Journal, 2026 Table 5 Multiple regression analysis of factors associated with PRSS (N = 433) Model B SE β t p 95% CI LL 95% CI UL (Constant) 11.850 1.120 - 10.57 < 0.001*** 9.64 14.06 Quick sequential organ failure assessment (qSOFA) 0.420 0.120 0.140 3.50 < 0.001*** 0.656 0.184 National early warning score (NEWS) 0.210 0.065 0.180 3.23 0.001** 0.338 0.082 Age -0.095 0.040 -0.095 -2.38 0.018* -0.174 -0.016 Gender 1.200 0.185 0.320 6.49 < 0.001*** 0.835 1.565 Known chronic disease 0.280 0.090 0.110 3.11 0.002** 0.103 0.457 Smoking status -0.250 0.110 -0.090 -2.27 0.024* -0.466 -0.034 Note. Values include unstandardized coefficients (B), 95% confidence intervals (CI), standard error (SE), standardised beta coefficients (β), and p-values; *= p <0.05, **= p < 0.01, ***= p < 0.001 was considered statistically significant, N = 433. Figure 1 Unstandardized Regression Coefficients (B) for Predictors of Patient-Reported Symptom Severity (PRSS) in ICU Patients with Septic Shock. Positive B indicates higher PRSS; negative B indicates lower PRSS. N = 433. negatively associated with PRSS. Discussion This study aimed to examine the associations between pre-existing clinical risk scales (qSOFA and NEWS 2) and patient-reported symptom severity in ICU patients with septic shock. These findings are descriptive and exploratory; they should not be interpreted as predictive of clinical outcomes. Such associations cannot be taken as a signal of prognostic or predictive value in the ICU environment. In the current study, qSOFA and NEWS showed a moderate positive correlation, indicating that patients who scored higher on one tool tended to score higher on the other. This is in accordance with earlier literature, which suggests that both qSOFA and NEWS tend to show higher values in patients with more severe clinical presen­ tations and often demonstrate parallel patterns13). In our research, patient-reported symptom severity was moderately associated with high qSOFA scores. This is in line with previous studies on acute decom­ pensated heart failure that indicate an increase in the level of symptoms with an increase in the qSOFA score to more serious symptoms like dyspnea14). Similarly, higher NEWS scores were associated with greater patient-reported symptom severity, thus supporting previous studies showing that they were associated with higher symptom burden15). Concerning the differences between genders, the males' scores on qSOFA and NEWS were higher, which corroborates the findings of previous ICU and ED studies that indicated male patients had higher qSOFA and NEWS scores than females, consistent with previous ICU studies16, 17). On the 7 Maqbool HM, et al: Clinical risk scores & symptoms in septic shock other hand, female participants showed much greater severity of the symptoms than the male ones; this is consistent with previous findings indi­ cating that women tend to report higher levels of symptom-related distress, especially pain, fatigue, and nausea18). Age was associated with differences in clinical severity scores and symptom perception. The older participants showed higher qSOFA and slightly higher NEWS scores, consistent with previous research demonstrating that older participants had higher qSOFA and slightly higher NEWS scores, consistent with previous findings19, 20). On the contrary, both patient-reported symptom severity and age were inversely related, consistent with previous findings that older people tend to report fewer and less severe symptoms across several areas and other domains21). The multiple regression analysis results revealed the variables related to patient-reported severity of the symptoms, corroborating prior studies linking clinical severity, sex, and age to symptom burden13, 15, 18, 21). Chronic disease was also associated with higher patient-reported symptom severity, which is in line with past studies that have shown that patients with chronic conditions suffer from a multitude of severe and bothersome symptoms that impair daily activities and the overall quality of life22). Smokers reported slightly lower symptom severity, though causality cannot be inferred, which is in line with earlier research that indicated the possibility of under-reporting or delayed recogni­ tion of symptoms in smokers23). Overall, these findings demonstrate significant associations between clinical severity scores, demo­ graphic characteristics, comorbidities, and patientreported symptom severity. Given the cross-sec­ tional design, these relationships should be inter­ preted as associative rather than causal. resulting in a younger sample that does not reflect the entire ICU septic shock population. The research was carried out in one tertiary-care ICU with a questionnaire-based methodology, and therefore cannot be generalised to other environments. Results are descriptive and exploratory, aimed at devel­ oping hypotheses rather than guiding clinical deci­ sion-making. Moreover, the study sample of patients with septic shock was relatively young, which may have been a convenience sample and also a result of the nature of the tertiary-care ICU. This skew in the population can restrict externalising the results to the general population of septically shocked, crit­ ically ill patients. The qSOFA score was originally developed for early risk stratification outside the ICU setting. In this study, qSOFA was applied solely to ICU patients for exploratory association analysis; therefore, the observed relationships should not be interpreted as evidence of predictive validity in critically ill populations. The patient-reported symptom severity scale (PRSS) is a locally devel­ oped instrument that has not undergone formal psychometric validation, including reliability testing and construct validity assessment. As such, the PRSS should be considered an exploratory measure, and findings on symptom severity should be inter­ preted with caution. In addition, alterations in the patient's consciousness, the use of a proxy, and errors in symptom recall may affect symptom reporting in seriously ill patients. Future research should employ prospective, longi­ tudinal, and multicentre designs to examine temporal relationships between clinical risk scores, patientreported symptoms, and subsequent clinical outcomes. Formal validation of symptom-based instruments, including psychometric testing, is necessary to enhance reliability and applicability across diverse ICU populations. Limitations and future directions There are several constraints that should be identified. Firstly, the cross-sectional, questionnairebased method does not allow one to infer causes. It does not allow for establishing the time correlation between high scores and the severity of symptoms with possible clinical deterioration. Moreover, selec­ tion bias may have occurred due to convenience sampling and single-centre recruitment, potentially In conclusion, the current study established that qSOFA and NEWS 2 are both correlated with the intensity of patient-reported symptoms in ICU patients with septic shock. The differences between genders and age groups emphasise the need to consider patient-reported symptom burden and clinical risk scores when characterising and explaining symptom burden and clinical severity among ICU patients. 8 Conclusion Juntendo Medical Journal, 2026 index and adjusted mortality in ICU patients with sepsis or septic shock: a systematic review and metaanalysis. Crit Care, 2016; 20: 181. 4) Bhatnagar M, Sirohi N, Dubey A: Prediction of hospital outcome in emergency medical admissions using modi­ fied early warning score (MEWS): Indian experience. J Fam Med Prim Care, 2021; 10: 192-198. 5) Mumtaz H, Ejaz MK, Muhammad Tayyab, et al: APACHE scoring as an indicator of mortality rate in ICU patients: a cohort study. Ann Med Surg, 2023; 85: 416-421. 6) Raith EP, Udy AA, Bailey M, et al: Prognostic Accu­ racy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit. JAMA, 2017; 317: 290-300. 7) Venkatesh K, Henschke A, Lee RP, Delaney A: Patientcentred outcomes are under-reported in the critical care burns literature: a systematic review. Trials, 2022; 23: 199. 8) Saltnes-Lillegård C, Tone Rustøen, Beitland S, et al: Self-reported symptoms experienced by intensive care unit patients: a prospective observational multicenter study. Intensive Care Med, 2023; 49: 1370-1382. 9) Saltnes-Lillegård C, Tone Rustøen, Beitland S, et al: Self-reported symptoms in ICU patients and their impact on long-term outcomes—a prospective multi­ center study. Intensive Care Med, 2025; 51: 1260-1270. 10) Naing L, Nordin RB, Abdul Rahman H, Naing YT: Sample size calculation for prevalence studies using Scalex and ScalaR calculators. BMC Med Res Methodol. 2022; 22: 209.. 11) Seymour CW, Liu VX, Iwashyna TJ, et al: Assessment of Clinical Criteria for Sepsis. JAMA, 2016; 315: 762-774. 12) Royal College of Physicians: National Early Warning Score (NEWS) 2 Standardising the assessment of acute-illness severity in the NHS. London, 2017. 13) Sabir L, Ramlakhan S, Goodacre S: Comparison of qSOFA and Hospital Early Warning Scores for prog­ nosis in suspected sepsis in emergency department patients: a systematic review. Emerg Med J, 2021; 39: 284-294. 14) Wagner T, Sinning C, Haumann J, et al: qSOFA Score Is Useful to Assess Disease Severity in Patients With Heart Failure in the Setting of a Heart Failure Unit (HFU). Front Cardiovasc Med, 2020; 7: 574768. 15) Chen L, Zheng H, Chen L, et al: National Early Warning Score in Predicting Severe Adverse Outcomes of Emergency Medicine Patients: A Retrospective Cohort Study. J Multidiscip Healthc, 2021; 14: 2067-2078. 16) Zimmermann T, Kaufmann P, Amacher SA, et al: Sex differences in the SOFA score of ICU patients with sepsis or septic shock: a nationwide analysis. Crit Care, 2024; 28: 209. 17) Candel BG, Dap S, Raven W, et al: Sex differences in clinical presentation and risk stratification in the Emer­ gency Department: An observational multicenter cohort study. Eur J Intern Med, 2022; 95: 74-79. 18) Falk H, Henoch I, Ozanne A, et al: Differences in Symptom Distress Based on Gender and Palliative Care Designation Among Hospitalized Patients. J Nurs Scholarsh, 2016; 48: 569-576. 19) Rosa GR, da R, Teixeira MB, et al: Prognostic ability of quick-SOFA across different age groups of patients with suspected infection outside the intensive care unit: A cohort study. J Crit Care, 2018; 47: 178-184. 20) Nissen SK, Candel BGJ, Nickel CH, et al: The Impact of Age on Predictive Performance of National Early Warning Score at Arrival to Emergency Departments: Development and External Validation. Ann Emerg Med, 2022; 79: 354-363. 21) Cataldo JK, Paul S, Cooper B, et al: Differences in the symptom experience of older versus younger oncology outpatients: a cross-sectional study. BMC Cancer, 2013; 13: 6. 22) ALHosni F, Al Qadire M, Omari OA, et al: Symptom prevalence, severity, distress and management among patients with chronic diseases. BMC Nurs, 2023; 22: 155. 23) Friedemann Smith C, Whitaker K, Winstanley K, Wardle J: Smokers are less likely than non-smokers to seek help for a lung cancer “alarm” symptom. Thorax, 2016; 71: 659-661. 9